Mark T. Iwicki - Insider Trading & Ownership

Location
84 Waterford Drive, Marlborough, MA
Summary
The estimated net worth of Mark T. Iwicki is at least $1.3M dollars as of October 27, 2025. Mark T. Iwicki is the Director of Akero Therapeutics, Inc. and owns shares of Akero Therapeutics, Inc. (AKRO) stock worth about $422K. Mark T. Iwicki is the Director of Q32 Bio Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $343K. Mark T. Iwicki is the Director of KALA BIO, Inc. and owns shares of KALA BIO, Inc. (KALA) stock worth about $212K. Mark T. Iwicki is the Director of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $205K. Mark T. Iwicki is the Director of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $120K.
Signature
/s/ Eric Bell, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Mark T. Iwicki

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AKRO Akero Therapeutics, Inc. Director $422K Jun 3, 2025
QTTB Q32 Bio Inc. Director $343K Oct 23, 2025
KALA KALA BIO, Inc. Director $212K -$138K -39.4% Oct 23, 2025
JBIO Jade Biosciences, Inc. Director $205K Jun 5, 2024
MRUS Merus N.V. Director $120K May 22, 2025
THRD Third Harmonic Bio, Inc. Director $0 Aug 11, 2025
IKT Inhibikase Therapeutics, Inc. Chief Executive Officer, Director Feb 21, 2025

Insider Transactions Reported by Mark T. Iwicki:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.